[1] Morgan TH, Bridges CB.The inheritance of a fluctuating character[J]. Journal of General Physiology, 1919, 1(6):639-643. [2] Phng LK, Gerhardt H.Angiogenesis:A team effort coordinated by Notch[J]. Developmental Cell, 2009, 16(2):196-208. [3] Ran QS, Yu YH, Fu XH, et al.Activation of the Notch signaling pathway promotes neurovascular repair after traumatic brain injury[J]. Neural Regeneration Research, 2015, 10(8):1258-1264. [4] Ikeuchi T, Sisodia SS.The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent “gamma-secretase” cleavage[J]. Journal of Biological Chemistry, 2003, 278(10):7751-7754. [5] Bentley K, Gerhardt H, Bates PA.Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation[J]. Journal of Theoretical Biology, 2008, 250(1):25-36. [6] Jubb AM, Turley H, Moeller HC, et al.Expression of delta-like ligand 4(Dll4)and markers of hypoxia in colon cancer[J]. British Journal of Cancer, 2009, 101(10):1749-1757. [7] 杨艳萍, 张国珍, 张云艳. DLL4蛋白在恶性肿瘤中的研究进展[J]. 现代肿瘤医学, 2016, 24(22):3687-3690. [8] Li Z, Wang J, Zhao C, et al.Acute blockage of Notch signaling by DAPT induces neuroprotection and neurogenesis in the neonatal rat brain after stroke[J]. Translational Stroke Research, 2016, 7(2):132-140. [9] 郎志强, 姜蕾, 吴艳秋, 等. 乳腺癌组织中DLL4、VEGF的表达变化及意义[J]. 山东医药, 2013, 53(3):55-57. [10] El-Zaemey S, Nagi N, Fritschi L, et al.Breast cancer among Yemeni women using the National Oncology Centre Registry 2004-2010[J]. Cancer Epidemiology, 2012, 36(3):249-253. [11] Wang Q, Ming YU, Wang G.Effect of RNAi silencing of the DLL4 gene on proliferation of human breast carcinoma cell MCF-7 cells[J]. Journal of Modern Oncology, 2012, 20(12):2476-2479. [12] Cao HQ.Correlation between the expression of Notch14 and DLL4 in lung squamous cell carcinoma and microvessel density[J]. China Journal of Clinical Experimental Pathology, 2012, 28(8):842-847. [13] Xun Y, Hua W, Xu H, et al.Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis[J]. Scientific Reports, 2015, 5(25):10338. [14] Li JL, Sainson RC, Shi W, et al.Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo[J]. Cancer Research, 2007, 67(23):11244. [15] He P, Liang J, Shao T, et al.HDAC5 promotes colorectal cancer cell proliferation by up-regulating DLL4 expression[J]. International Journal of Clinical & Experimental Medicine, 2015, 8(4):6510-6516. [16] 王泽根, 解伟, 许卓斌, 等. 重组人Dll4真核载体的构建及其在CHO细胞中的表达[J]. 药物生物技术, 2015(1):1-4. [17] Lee D, Kim D, Yu BC, et al.Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis[J]. Mabs, 2016, 8(5):892-904. [18] Baharlou R, Tajik N, Habibi-Anbouhi M, et al.Generation and characterization of an anti-delta like ligand-4 Nanobody to induce non-productive angiogenesis[J]. Analytical Biochemistry, 2018, 544:34-41. [19] 王甲业, 陈文江, 李妍, 等. 外源性组织型纤溶酶原激活物信号肽突变体增强蛋白质在哺乳细胞中的表达及分泌[J]. 国际免疫学杂志, 2010, 33(5):403-405. [20] 叶建斌, 梁来妹, 陈中标, 等. 人Notch配体DLL4基因的克隆及真核表达[J]. 生物技术, 2015(3):223-226. |